ANGELICOLA, STEFANIA
 Distribuzione geografica
Continente #
AS - Asia 1.163
EU - Europa 607
NA - Nord America 496
AF - Africa 50
SA - Sud America 35
OC - Oceania 1
Totale 2.352
Nazione #
US - Stati Uniti d'America 480
CN - Cina 462
IT - Italia 359
VN - Vietnam 256
SG - Singapore 216
KR - Corea 65
NL - Olanda 62
HK - Hong Kong 53
DE - Germania 48
IN - India 29
BR - Brasile 23
FI - Finlandia 22
BD - Bangladesh 20
FR - Francia 19
JP - Giappone 19
CI - Costa d'Avorio 16
GB - Regno Unito 16
AT - Austria 13
ZA - Sudafrica 13
CH - Svizzera 11
IE - Irlanda 10
RU - Federazione Russa 9
SE - Svezia 9
CA - Canada 7
IQ - Iraq 7
SC - Seychelles 7
PH - Filippine 6
TH - Thailandia 6
UA - Ucraina 6
AR - Argentina 5
MX - Messico 5
TW - Taiwan 4
DZ - Algeria 3
EC - Ecuador 3
EG - Egitto 3
ID - Indonesia 3
LT - Lituania 3
PL - Polonia 3
DK - Danimarca 2
GE - Georgia 2
HR - Croazia 2
IR - Iran 2
JM - Giamaica 2
JO - Giordania 2
LI - Liechtenstein 2
MA - Marocco 2
MY - Malesia 2
PK - Pakistan 2
TG - Togo 2
TR - Turchia 2
UZ - Uzbekistan 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AU - Australia 1
BB - Barbados 1
BE - Belgio 1
BG - Bulgaria 1
BJ - Benin 1
CL - Cile 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ES - Italia 1
GI - Gibilterra 1
GM - Gambi 1
HU - Ungheria 1
KG - Kirghizistan 1
LV - Lettonia 1
MN - Mongolia 1
MU - Mauritius 1
PT - Portogallo 1
PY - Paraguay 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
Totale 2.352
Città #
Shanghai 167
Singapore 166
Hefei 145
Bologna 106
Ho Chi Minh City 79
Ashburn 64
Seoul 63
Hanoi 62
San Jose 55
Hong Kong 49
Council Bluffs 42
Milan 36
Dallas 28
Los Angeles 22
New York 21
Boardman 20
Beijing 18
Abidjan 16
Casalecchio di Reno 16
Houston 16
Santa Clara 16
Bengaluru 12
Da Nang 11
Lauterbourg 11
Tokyo 11
Dublin 10
Johannesburg 10
Lappeenranta 10
Vienna 10
Amsterdam 9
Bern 9
Frankfurt am Main 9
Rimini 9
Haiphong 8
Chandler 7
Chicago 7
Helsinki 7
Kerpen 7
Vicenza 7
Falkenstein 6
Kyiv 6
Turin 6
Biên Hòa 5
Bo 5
Bremen 5
Cimitile 5
Parma 5
São Paulo 5
Tongling 5
Turku 5
Bangkok 4
Bluffdale 4
Bắc Giang 4
Bến Tre 4
Cambridge 4
Fairfield 4
Guangzhou 4
Modena 4
Munich 4
Naples 4
Rome 4
Wangen 4
Algiers 3
Baghdad 3
Bergamo 3
Boydton 3
Buffalo 3
Can Tho 3
Castenaso 3
Hải Dương 3
Montreal 3
Orem 3
Poplar 3
Porto Recanati 3
Redondo Beach 3
San Francisco 3
Southend 3
Thái Nguyên 3
Visakhapatnam 3
Wilmington 3
Woodbridge 3
Amman 2
Bari 2
Barnet 2
Bexley 2
Buenos Aires 2
Cento 2
Chennai 2
Chieti 2
Dalian 2
Florence 2
Guayaquil 2
Ha Long 2
Hamburg 2
Jakarta 2
Lomé 2
London 2
Long Xuyen 2
Lucca 2
Lấp Vò 2
Totale 1.572
Nome #
IFN-γ and CD38 in Hyperprogressive Cancer Development 439
PD-L1 and IFN-γ modulate Non-Small Cell Lung Cancer (NSCLC) cell plasticity associated to immune checkpoint inhibitor (ICI)-mediated hyperprogressive disease (HPD) 231
ADK-VR2, a cell line derived from a treatment-naïve patient with SDC4-ROS1 fusion-positive primarily crizotinib-resistant NSCLC: a novel preclinical model for new drug development of ROS1- rearranged NSCLC 216
Targeting PCSK9, through an innovative cVLP-based vaccine, enhanced the therapeutic activity of a cVLP-HER2 vaccine in a preclinical model of HER2-positive mammary carcinoma 213
Functional evaluation of circulating anti-cancer antibodies with a 3D tumor cell growth inhibition assay 211
Clinical and Preclinical Activity of EGFR Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer Harboring BRAF Class 3 Mutations 204
Lipid rafts, caveolae, and epidermal growth factor receptor family: friends or foes? 200
Virus-like Particle (VLP) Vaccines for Cancer Immunotherapy 185
Prevention and Therapy of Metastatic HER-2+ Mammary Carcinoma with a Human Candidate HER-2 Virus-like Particle Vaccine 180
Preclinical activity of ES2B-C001, a human candidate HER-2 virus-like particle (VLP) vaccine, against mammary carcinoma onset and metastasis 146
Development of cellular models expressing cynomolgus (Macaca fascicularis) HER2 for the functional evaluation of cross-reactive anti-human HER2 response 77
Targeting HGF/MET and CXCL1/CXCR2 axes bypasses resistance to KRASG12C inhibitors in NSCLC 59
Alternatives for fetal bovine serum (FBS) and sustainability of milk derivatives in cell culture 30
Requalified bovine milk as a sustainable supplement for cell cultures 24
HER-2 therapeutic vaccine is not hampered by concurrent HER-2 monoclonal antibody 12
Totale 2.427
Categoria #
all - tutte 5.516
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.516


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202227 3 3 1 2 5 3 1 0 3 1 3 2
2022/2023108 2 2 2 11 13 13 12 5 16 3 13 16
2023/2024270 5 2 21 17 16 13 7 175 2 6 2 4
2024/2025527 10 33 18 15 52 27 76 40 6 76 58 116
2025/20261.416 117 249 114 125 80 58 100 37 251 102 84 99
2026/202741 41 0 0 0 0 0 0 0 0 0 0 0
Totale 2.427